Gardasil – cervical cancer vaccine offered to all boys as well

NewsGuard 100/100 Score

Soon all adolescent boys may be vaccinated against the sexually transmitted disease that causes some forms of cancer under an extension of a scheme now available to girls, the Australian government's expert panel has recommended. The committee adds that the shots would also widen immunity to the virus, which would further reduce the risk to women and stem the spread of genital warts in both sexes.

The Pharmaceutical Benefits Advisory Committee has proposed Gardasil vaccinations, available to all girls to protect against cervical cancer, should be administered to boys to prevent throat and anus cancers triggered by the human papilloma virus (HPV). About 400 cases a year can be attributed to the virus. The Gardasil vaccinations have already slashed by about half the number of new cases of cervical cancer, of which there are now about 700 a year.

The initial cost of administering Gardasil to all girls at age 13, together with catch-ups for older age groups, was about $450 million over four years when the vaccination scheme began after intense debate over cost benefits five years ago.

The federal government yesterday said it would consider the advisory committee's recommendations, which include that Gardasil be given to boys at about 12 to 13 years of age and given as a catch-up for boys in the 14 to 15 age group. The committee states its recommendations are on the basis it would be cost-effective to vaccinate boys as well as girls.

HPV specialist Karen Canfell said the decision to extend the vaccination involved a complex assessment of cost-effectiveness, given the success of Gardasil in reducing cervical cancer, which has been more widespread than the HPV-linked cancers in men. The chief executive of the Cancer Council of Australia, Ian Olver, welcomed the recommendation as a step that would maximize the benefit of the vaccine, developed largely by Australian medical scientist Ian Frazer.

A Department of Health spokeswoman said there were steps that must be undertaken before a listing of Gardasil for boys was finalized, including pricing agreement and guarantee of supply. If the government were to approve the vaccine program, it would not be expected to start next year because of the arrangements needed, including an amendment to legislation and planning logistics with the states and territories.

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2020, April 03). Gardasil – cervical cancer vaccine offered to all boys as well. News-Medical. Retrieved on April 19, 2024 from

  • MLA

    Mandal, Ananya. "Gardasil – cervical cancer vaccine offered to all boys as well". News-Medical. 19 April 2024. <>.

  • Chicago

    Mandal, Ananya. "Gardasil – cervical cancer vaccine offered to all boys as well". News-Medical. (accessed April 19, 2024).

  • Harvard

    Mandal, Ananya. 2020. Gardasil – cervical cancer vaccine offered to all boys as well. News-Medical, viewed 19 April 2024,


  1. ab ab Australia says:

    The stats in this report are wrong. If there are still "around 700 new cases" in 2011, it's nothing to boast about. Annual figures were reducing drastically prior to this.

    Australian Govt reports said,

    "Across all age groups there were 735 new cases of cervical cancer detected in Australia in 2001, a sharp decline from 1,089 in 1991 when organised screening started."

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New microfluidic device improves the separation of tumor cells and clusters from malignant effusions